Environmental persistent pharmaceutical pollutant
The term environmental persistent pharmaceutical pollutants (EPPP) was first suggested in the nomination in 2010 of pharmaceuticals and environment as an emerging issue in a Strategic Approach to International Chemicals Management (SAICM) by the International Society of Doctors for the Environment (ISDE). The occurring problems from EPPPs are in parallel explained under environmental impact of pharmaceuticals and personal care products (PPCP). The European Union summarizes pharmaceutical residues with the potential of contamination of water and soil together with other micropollutants under "priority substances". Background Pharmaceuticals comprise one of the few groups of chemicals that are specifically designed to act on living cells, which presents a special risk when they enter, persist and are dispersed into the environment. With the exception of watercourses downstream of sewage treatment plants, the concentration of pharmaceuticals in surface and ground water is generally low. Concentrations in sewage sludge and in landfill leachate may be substantially higher and provide alternative routes for EPPPs to enter the human and animal food-chain. However, even at very low environmental concentrations, the chronic exposure to environmental pharmaceuticals chemicals can add to the effects of other chemicals in the cocktail is still not studied. The different chemicals might be potentiating synergistic